{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:25:29Z","timestamp":1794983129391,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SB\/S9\/Z-16\/2016-X (2022)"],"award-info":[{"award-number":["SB\/S9\/Z-16\/2016-X (2022)"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s13346-024-01785-6","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T15:47:10Z","timestamp":1736264830000},"page":"2862-2877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Oral delivery of dihydroartemisinin for the treatment of melanoma via bovine milk exosomes"],"prefix":"10.1007","volume":"15","author":[{"given":"Dulla Naveen","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiswarya","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Dehari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin M.","family":"Gamper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7302-3647","authenticated-orcid":false,"given":"Ashish Kumar","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"issue":"1","key":"1785_CR1","first-page":"1","volume":"1","author":"D Schadendorf","year":"2015","unstructured":"Schadendorf D, et al. Melanoma. 2015;1(1):1\u201320.","journal-title":"Melanoma"},{"key":"1785_CR2","doi-asserted-by":"crossref","unstructured":"Ali Z, Yousaf N, Larkin JJEJoCS. Melanoma epidemiology, biology and prognosis. 2013;11(2): 81\u201391.","DOI":"10.1016\/j.ejcsup.2013.07.012"},{"key":"1785_CR3","doi-asserted-by":"crossref","unstructured":"Domingues B et al. Melanoma treatment in review. 2018;35\u201349.","DOI":"10.2147\/ITT.S134842"},{"key":"1785_CR4","doi-asserted-by":"crossref","unstructured":"Mohapatra D et al. Quality-by-design-based development of ultradeformable nanovesicular transgelosome of standardized Piper longum extract for melanoma. 2023(0).","DOI":"10.2217\/nnm-2023-0069"},{"key":"1785_CR5","doi-asserted-by":"crossref","unstructured":"Papadopoulos NE, et al. Phase I\/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma. 2009;32(5):509\u2013514.","DOI":"10.1097\/COC.0b013e3181942a1f"},{"key":"1785_CR6","doi-asserted-by":"crossref","unstructured":"Marsh JCJH. Hepatic vascular toxicity of dacarbazine (DTIC): not a rare complication. 1989;9(5):790\u2013792.","DOI":"10.1002\/hep.1840090521"},{"key":"1785_CR7","doi-asserted-by":"crossref","unstructured":"Myint H et al. Efficacy and safety of dihydroartemisinin-piperaquine. 2007;101(9):858\u2013866.","DOI":"10.1016\/j.trstmh.2007.05.018"},{"key":"1785_CR8","doi-asserted-by":"crossref","unstructured":"Dai X et al. Dihydroartemisinin: a potential natural anticancer drug. 2021;17(2):603.","DOI":"10.7150\/ijbs.50364"},{"key":"1785_CR9","doi-asserted-by":"crossref","unstructured":"Phung CD et al. PEGylated-paclitaxel and dihydroartemisinin nanoparticles for simultaneously delivering paclitaxel and dihydroartemisinin to colorectal cancer. 2020;37:1-11","DOI":"10.1007\/s11095-020-02819-7"},{"key":"1785_CR10","doi-asserted-by":"crossref","unstructured":"Pegtel DM, Gould SJJArob. Exosomes. 2019;88:487\u2013514.","DOI":"10.1146\/annurev-biochem-013118-111902"},{"key":"1785_CR11","doi-asserted-by":"crossref","unstructured":"Kalluri RJTJoci. The biology and function of exosomes in cancer. 2016;126(4):1208\u20131215.","DOI":"10.1172\/JCI81135"},{"key":"1785_CR12","doi-asserted-by":"crossref","unstructured":"Munagala R et al. Bovine milk-derived exosomes for drug delivery. 2016;371(1):48-61.","DOI":"10.1016\/j.canlet.2015.10.020"},{"key":"1785_CR13","doi-asserted-by":"crossref","unstructured":"Kumar DN et al. Exosomes as emerging drug delivery and diagnostic modality for breast cancer: recent advances in isolation and application. 2022;14(6):1435","DOI":"10.3390\/cancers14061435"},{"key":"1785_CR14","doi-asserted-by":"crossref","unstructured":"Agrawal AK et al. Milk-derived exosomes for oral delivery of paclitaxel. 2017;13(5):1627-1636","DOI":"10.1016\/j.nano.2017.03.001"},{"key":"1785_CR15","doi-asserted-by":"crossref","unstructured":"Munagala R et al. Exosomal formulation of anthocyanidins against multiple cancer types. 2017;393:94-102","DOI":"10.1016\/j.canlet.2017.02.004"},{"key":"1785_CR16","doi-asserted-by":"crossref","unstructured":"Aqil F et al. Exosomes for the enhanced tissue bioavailability and efficacy of curcumin. 2017;19:1691-1702","DOI":"10.1208\/s12248-017-0154-9"},{"key":"1785_CR17","doi-asserted-by":"crossref","unstructured":"Kumar DN et al. Combination therapy comprising paclitaxel and 5-fluorouracil by using folic acid functionalized bovine milk exosomes improves the therapeutic efficacy against breast cancer. 2022;12(8):1143.","DOI":"10.3390\/life12081143"},{"key":"1785_CR18","doi-asserted-by":"crossref","unstructured":"Kim MS et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. 2016;12(3):655-664","DOI":"10.1016\/j.nano.2015.10.012"},{"key":"1785_CR19","doi-asserted-by":"crossref","unstructured":"Kushwah V et al. Co-delivery of docetaxel and gemcitabine using PEGylated self-assembled stealth nanoparticles for improved breast cancer therapy. 2018;14(5):1629-1641.","DOI":"10.1016\/j.nano.2018.04.009"},{"key":"1785_CR20","doi-asserted-by":"crossref","unstructured":"Di Pace AL et al. Characterization of human NK cell-derived exosomes: role of DNAM1 receptor in exosome-mediated cytotoxicity against tumor. 2020;12(3):661.","DOI":"10.3390\/cancers12030661"},{"key":"1785_CR21","doi-asserted-by":"crossref","unstructured":"Chary PS et al. Design, fabrication and evaluation of stabilized polymeric mixed micelles for effective management in cancer therapy. 2022;39(11):2761\u20132780.","DOI":"10.1007\/s11095-022-03395-8"},{"key":"1785_CR22","doi-asserted-by":"crossref","unstructured":"Minocha T et al. Melatonin induces apoptosis and cell cycle arrest in cervical cancer cells via inhibition of NF-\u03baB pathway. 2022;30(4):1411-1429","DOI":"10.1007\/s10787-022-00964-6"},{"key":"1785_CR23","doi-asserted-by":"crossref","unstructured":"Saneja A et al. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. 2017;531(1):153-166","DOI":"10.1016\/j.ijpharm.2017.08.076"},{"key":"1785_CR24","doi-asserted-by":"crossref","unstructured":"Conesa CM et al. In vitro and in vivo effect of IFN\u03b1 on B16F10 melanoma in two models: Subcutaneous (C57BL6J mice) and lung metastasis (Swiss mice). 2009;63(4):305\u2013312.","DOI":"10.1016\/j.biopha.2008.07.092"},{"key":"1785_CR25","doi-asserted-by":"crossref","unstructured":"Kandimalla R et al. Targeted oral delivery of paclitaxel using colostrum-derived exosomes. 2021;13(15):3700","DOI":"10.3390\/cancers13153700"},{"key":"1785_CR26","doi-asserted-by":"crossref","unstructured":"Rai Y et al. Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. 2018;8(1):1531","DOI":"10.1038\/s41598-018-19930-w"},{"key":"1785_CR27","doi-asserted-by":"crossref","unstructured":"Hou J et al. Experimental therapy of hepatoma with artemisinin and its derivatives: in vitro and in vivo activity, chemosensitization, and mechanisms of action. 2008;14(17):5519\u20135530.","DOI":"10.1158\/1078-0432.CCR-08-0197"},{"key":"1785_CR28","doi-asserted-by":"crossref","unstructured":"Shen Y et al. Iron promotes dihydroartemisinin cytotoxicity via ROS production and blockade of autophagic flux via lysosomal damage in osteosarcoma. 2020;11:444.","DOI":"10.3389\/fphar.2020.00444"},{"key":"1785_CR29","doi-asserted-by":"crossref","unstructured":"Mohapatra D et al. Quality by design\u2013based development and optimization of fourth-generation ternary solid dispersion of standardized Piper longum extract for melanoma therapy. 2023;1\u201338.","DOI":"10.21203\/rs.3.rs-2673548\/v1"},{"key":"1785_CR30","doi-asserted-by":"crossref","unstructured":"Miller KD et al. Cancer treatment and survivorship statistics, 2022. 2022;72(5):409\u2013436.","DOI":"10.3322\/caac.21731"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01785-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01785-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T16:45:08Z","timestamp":1751388308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01785-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1785"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01785-6","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,7]]},"assertion":[{"value":"23 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional Animal Ethics Committee (IAEC) of Indian Institute of Technology (BHU) Varanasi approved the animal study used in the study with reference number IIT (BHU)\/IAEC\/2023\/002.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable since study did not include humans.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors confirm that they do not have any known financial or interpersonal conflicts of interest that could have influenced the research presented in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}